Halozyme Therapeutics Inc (HALO)

[biotechinvestor1]

Here is yet another success story with Pegph20 and prolonged progression free survival. Read all the way to the last post (November update). Nearly a year of PFS with PEGPH20.

No doubt this patient was in the PEGPH20 group (as opposed to your highly unlikely speculation that the control group is somehow miraculously doing well despite all historal data we have on standard chemo).
As you can see in this link and as I have been saying all along, it's an open label study. Patients and oncologists know what they are getting/giving.

With so many success stories out there, soon the oncologists and DMC will demand that the control group pts who progressed and dropped out of study, be given PEGPH20 for ethical reasons and for compassionate use. The control group pt will demand it as well.

https://www.cancerforums.net/threads/47655-New-Poster-Mom-is-Stage-4-and-in-Clinical-Trial?highlight=PegpH20